Long-term Debt and Lease Obligation in USD of AYTU BIOPHARMA, INC from Q2 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of long-term debt and lease obligation, classified as noncurrent.
Summary
Aytu Biopharma, Inc quarterly Long-term Debt and Lease Obligation history and growth rate from Q2 2020 to Q3 2025.
  • Aytu Biopharma, Inc Long-term Debt and Lease Obligation for the quarter ending September 30, 2025 was $10.4M, a 0.16% increase year-over-year.
Long-term Debt and Lease Obligation, Quarterly (USD)
Long-term Debt and Lease Obligation, YoY Quarterly Growth (%)

AYTU BIOPHARMA, INC Quarterly Long-term Debt and Lease Obligation (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $10.4M +$17K +0.16% Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $10.9M +$18K +0.17% Jun 30, 2025 10-Q 2025-11-13
Q1 2025 $9.54M +$9.54M Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $9.98M -$5M -33.3% Dec 31, 2024 10-Q 2025-02-12
Q3 2024 $10.4M -$4.41M -29.7% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $10.9M -$3.84M -26.1% Jun 30, 2024 10-K 2025-09-23
Q1 2024 $0 -$11.4M -100% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $15M +$445K +3.06% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $14.8M +$1.28M +9.45% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $14.7M +$434K +3.04% Jun 30, 2023 10-K 2024-09-26
Q1 2023 $11.4M -$2.78M -19.6% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $14.5M +$14.4M +11166% Dec 31, 2022 10-Q 2023-02-21
Q3 2022 $13.6M +$13.4M +8705% Sep 30, 2022 10-Q/A 2023-02-21
Q2 2022 $14.3M +$14.1M +7833% Jun 30, 2022 10-K 2023-10-12
Q1 2022 $14.2M Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $129K Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $154K Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $180K +$180K Jun 30, 2021 10-K 2022-09-27
Q2 2020 $0 Jun 30, 2020 10-K 2021-09-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.